CAROLINE SIMS: Open Payments
NPI 1033852264 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 10 payments from 7 companies in 2025. Trend: 2023 $19 · 2024 $65 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $47 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Lilly USA, LLC | 2 | $39 |
| ABIOMED | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Smith+Nephew, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Bimzelx, TZIELD, INSPIRE, REDAPT, MOUNJARO, SPEVIGO, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
